- Home
- QNST vs TVTX Comparison
QNST vs TVTX Comparison
Compare QNST & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNST
- TVTX
- Stock Information
- Founded
- QNST 1999
- TVTX 2008
- Country
- QNST United States
- TVTX United States
- Employees
- QNST N/A
- TVTX N/A
- Industry
- QNST Business Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- QNST Consumer Discretionary
- TVTX Health Care
- Exchange
- QNST Nasdaq
- TVTX Nasdaq
- Market Cap
- QNST 1.1B
- TVTX 1.7B
- IPO Year
- QNST 2010
- TVTX N/A
- Fundamental
- Price
- QNST $15.68
- TVTX $21.54
- Analyst Decision
- QNST Strong Buy
- TVTX Strong Buy
- Analyst Count
- QNST 7
- TVTX 14
- Target Price
- QNST $28.29
- TVTX $33.31
- AVG Volume (30 Days)
- QNST 791.7K
- TVTX 1.6M
- Earning Date
- QNST 05-07-2025
- TVTX 05-01-2025
- Dividend Yield
- QNST N/A
- TVTX N/A
- EPS Growth
- QNST N/A
- TVTX N/A
- EPS
- QNST N/A
- TVTX N/A
- Revenue
- QNST $1,029,978,000.00
- TVTX $273,533,000.00
- Revenue This Year
- QNST $80.76
- TVTX $68.31
- Revenue Next Year
- QNST $9.11
- TVTX $55.65
- P/E Ratio
- QNST N/A
- TVTX N/A
- Revenue Growth
- QNST 88.81
- TVTX 75.65
- 52 Week Low
- QNST $14.39
- TVTX $6.01
- 52 Week High
- QNST $26.27
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- QNST 41.57
- TVTX 65.30
- Support Level
- QNST $14.69
- TVTX $19.65
- Resistance Level
- QNST $19.29
- TVTX $22.07
- Average True Range (ATR)
- QNST 0.85
- TVTX 1.16
- MACD
- QNST -0.17
- TVTX 0.32
- Stochastic Oscillator
- QNST 21.52
- TVTX 90.99
About QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.